Home > Income Statement > AUROBINDO PHARMA
AD     Remove this Ad

AUROBINDO PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹31,724 Cr₹29,002 Cr₹24,855 Cr₹23,455 Cr₹24,775 Cr

What is the latest Revenue of AUROBINDO PHARMA ?

The latest Revenue ratio of AUROBINDO PHARMA is ₹31,724 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹31,724 Cr
Mar2024₹29,002 Cr
Mar2023₹24,855 Cr
Mar2022₹23,455 Cr
Mar2021₹24,775 Cr

How is Revenue of AUROBINDO PHARMA Trending?

Years Revenue % Change
Mar2025 ₹31,724 Cr
9.39
Mar2024 ₹29,002 Cr
16.68
Mar2023 ₹24,855 Cr
5.97
Mar2022 ₹23,455 Cr
-5.32
Mar2021 ₹24,775 Cr -

Compare Revenue of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹74,772.2 Cr -1.3% 12.1% 17.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,825.0 Cr -1.6% 5.7% 7.7% Stock Analytics
DIVIS LABORATORIES ₹161,535.0 Cr -4.2% -1.4% 9.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,733.0 Cr -2.8% 5.7% 39.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,094.0 Cr -3.2% 1.2% 14.2% Stock Analytics
CIPLA ₹103,513.0 Cr -3.6% -3.7% -10.2% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-1.3%

12.1%

17.3%

SENSEX

-2.7%

-9.1%

2.6%


You may also like the below Video Courses